Literature DB >> 35506004

Using Immunomodulatory and Antiviral Strategies in the Quest to Cure Hepatitis B Virus Infection.

Adam J Gehring1.   

Abstract

Entities:  

Year:  2022        PMID： 35506004      PMCID： PMC9053486     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies.

Authors:  Adam J Gehring
Journal:  Best Pract Res Clin Gastroenterol       Date:  2017-05-25       Impact factor: 3.043

Review 2.  Getting to HBV cure: The promising paths forward.

Authors:  Scott Fung; Hannah S J Choi; Adam Gehring; Harry L A Janssen
Journal:  Hepatology       Date:  2022-02-16       Impact factor: 17.298

3.  Immunomodulation and RNA interference alter hepatitis B virus-specific CD8 T-cell recognition of infected HepG2-NTCP.

Authors:  Adrian Kuipery; Juan Diego Sanchez Vasquez; Aman Mehrotra; Jordan J Feld; Harry L A Janssen; Adam J Gehring
Journal:  Hepatology       Date:  2022-01-08       Impact factor: 17.298

Review 4.  Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.

Authors:  Adam J Gehring; Ulrike Protzer
Journal:  Gastroenterology       Date:  2018-10-24       Impact factor: 22.682

Review 5.  Future Therapy for Hepatitis B Virus: Role of Immunomodulators.

Authors:  Edward A Pham; Ryan B Perumpail; Benjamin J Fram; Jeffrey S Glenn; Aijaz Ahmed; Robert G Gish
Journal:  Curr Hepatol Rep       Date:  2016-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.